MONTREAL, January 24, 2022 /PRNewswire/ – Montreal based Puzzle Medical Devices Inc., a medical device company developing a percutaneous heart pump for patients with advanced heart failure (HF), announced today the closing of its major Seed financing round. Participants include US-based Broadview Ventures, Grant Park Ventures and Cathexis Ventures, as well as Canada-based asterX Capital, Anges Québec – AQC Capital and Boreal Ventures. Having demonstrated the safety and efficacy of its device in preclinical studies and obtained Breakthrough Device designation by the FDA, Puzzle Medical’s Seed financing round will now fund the first-in-human study of the ModulHeart mechanical circulatory support (MCS) device.